ALicon.ch
Visit Website |
|
edit Title
alicon AG - breakthrough products setting a new standard in TSE diagnostics and prion filtration
edit Description
Excerpted from the website:
- The Swiss biotechnology company alicon AG, founded in 2004, specializes in developing innovative technologies to detect and filtrate pathogenic prions in blood from animals and humans.
- Within the diagnostic sector, alicon is particularly active and well-positioned as a pioneer in developing the first ante mortem TSE testing procedures. The firm’s business concept is based on the design of a novel process that can confirm the presence of prions in blood from humans and animals.
- In the bio-safety sector, alicon is developing procedures allowing filtration of prions from blood plasma products and culture medium.
edit Additional Information
Categories:
Alicon | Alicon Ag | Alzheimer | Ante Mortem | Antibody | Biochemistry and Molecular Biology | Biology | Biotech | Biotechnology | Blood | Bse | Cattle | Company | Diagnostics | Doppel | Dpl | Dpl-pure | Drug | Eth | Gene Expression | List | Neurodegenerative Disease | Neuroscience | Price | Pricelist | Prion | Products and Services | Protein | Prp | Prp-beta | Prp-pure | Prpc | Prpsc | Reagents and Kits | Recombinant | Recombinant Prion Protein | Research | Science | Spin-off | Therapy | Tse | Zahn- get page alerts
- Influence Us
-
close
Close Me


